The companies and institutions leading samRNA therapeutics, the number of developing candidates across indications, and the highest stage of clinical development reached by any candidate so far
Arcturus Therapeutics | 6 | Approved | |
---|---|---|---|
Gritstone Bio | 4 | 2 | Phase III |
VLP Therapeutics | 3 | 1 | Phase III |
Gennova Biopharmaceuticals | 1 | Phase II/approved | |
Strand Therapeutics | 4 | Phase II | |
Elixirgen Therapeutics | 1 | Phase II | |
Pfizer | 7 | Phase I | |
Immorna Hangzhou Biotechnology | 2 | 1 | Phase I |
MRC/UVRI | 1 | Phase I |